Skip to content
BeiGene (BGNE) and Assembly Biosciences (ASMB) have announced a new collaboration in China for Assembly’s three clinical-stage core inhibitor candidates for the treatment of chronic hepatitis B virus (HBV) infection. Shares in ASMB are surging 9% in Monday’s pre-market trading, while BGNE is up 3%.Under the terms of the agreement, Assembly has granted BeiGene exclusive rights to develop and commercialize ABI-H0731, ABI-H2158 and ABI-H3733 in China, including Hong Kong, Macau, and Taiwan. ABI-H0731 and ABI-H2158 are in ongoing Phase 2 clinical trials and ABI-H3733 is in Phase 1 development.BeiGene will be responsible for development, regulatory submissions, and commercialization in China. Assembly retains full worldwide rights outside of the partnered territory for its HBV portfolio.Assembly will receive an upfront cash payment of $40 million plus up to $500 million in potential development, regulatory and net sales milestone payments. Assembly is also eligible to receive tiered royalties of net sales. BeiGene will contribute initial funding for clinical development in China, after...
(Bloomberg) -- Billionaire Jack Ma’s Ant Group is seeking a valuation north of $200 billion as it goes public in Hong Kong and Shanghai, people familiar with the matter said, kicking off a landmark coming-out party for China’s leader in internet finance.The parent of China’s largest mobile payment company will pursue a simultaneous dual-listing in Hong Kong and on the Shanghai stock exchange’s STAR board, the Hangzhou-based firm said, in what promises to be one of the largest debuts in years. Ant is already more richly valued than most Wall Street firms and, if conditions are favorable, it could seek to raise more in its IPOs than Saudi Aramco’s record $29 billion haul, one of the people said, asking not to be identified talking about a private deal.The crown jewel of the sprawling Alibaba empire, Ant has been accelerating its evolution into an online mall for everything from loans and travel...
(Bloomberg) -- Angela Merkel promoted Wirecard AG during a past state visit to China, the latest revelation about the government’s association with the fallen German tech darling.Opposition lawmakers are threatening to call for a parliamentary investigation as they press Merkel’s administration over how it pursued fraud allegations against a member of Germany’s benchmark DAX index.Underscoring the impact of the scandal, the finance committee in Germany’s lower house of parliament plans to interrupt the summer recess to hold a special session on July 29 to discuss Wirecard.Finance Minister Olaf Scholz and Economy Minister Peter Altmaier have been invited, as well as officials from the government’s Financial Reporting Enforcement Panel, according to Daniel Bayaz, a lawmaker from the Green party.‘Last Chance’“The government needs to end its piecemeal approach and finally put everything on the table,” Bayaz said via email, calling next week’s hearing the “last chance” for the government to avoid a parliamentary...
One thing we could say about the analysts on Talos Energy Inc. (NYSE:TALO) - they aren't optimistic, having just made......
Digital Turbine, Inc. (NASDAQ:APPS), might not be a large cap stock, but it received a lot of attention from a......
A look at the shareholders of Maxar Technologies Inc. (NYSE:MAXR) can tell us which group is most powerful. Generally......
